Rheumatoid Arthritis Quiz: Bridging Therapy

Article

Glucocorticoids are sometimes used as “bridging” therapy to alleviate symptoms in newly diagnosed patients with rheumatoid arthritis until a disease-modifying antirheumatic drug (DMARD) kicks in. Test your knowledge of bridging therapy with this quiz.

In 2021 the American College of Rheumatology conditionally recommended that a conventional synthetic DMARD is initiated without short-term (<3 months) glucocorticoids. Its previous 2015 guideline for the Treatment of Rheumatoid Arthritis had recommended use of glucocorticoids as bridging therapy in patients with early rheumatoid arthritis with moderate to high disease activity until the benefits of DMARD therapy are realized. What specific reason did the American College of Rheumatology give for its change of view?


Related Videos
4 KOLs are featured in this series
4 KOLs are featured in this series
M. Safwan Badr, MD: Novel Treatments for Central Sleep Apnea in Last 10 Years
Video 4 - Featuring 3 KOLs in, "Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease "
Video 3 - Featuring 3 KOLs in, "How important is transmural healing as a treatment target in UC and CD?   Where does intestinal ultrasound fit in CD management?  "
How Elite Athletes Can Optimize Sleep for Peak Performance, with Jesse D. Cook, PhD
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
HCPLive Five at ADA 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.